AGTI:NYE-Agiliti Inc (USD)

COMMON STOCK | Health Information Services | NYE

Last Closing Price

USD 20.02

Change

-0.75 (-3.61)%

Market Cap

USD 2.92B

Volume

0.17M

Avg Analyst Target

USD 21.96 (+9.68%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Agiliti, Inc. provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity; and clinical engineering services comprising maintenance, repair, and remediation solutions for various type of medical equipment, including general biomedical and diagnostic imaging equipment through supplemental and outsourced offerings. It also provides equipment solutions, which primarily provide supplemental, peak need, and per-case rental of general biomedical, specialty, and surgical equipment to acute care hospitals and alternate site providers, including premier healthcare institutions and integrated delivery networks. As of December 31, 2020, it owned or managed approximately a million units of medical equipment for approximately 7,000 national, regional, and local acute care hospitals, health system integrated delivery networks, and alternate site providers. Agiliti, Inc. was founded in 2018 and is headquartered in Minneapolis, Minnesota.

Company Website : http://www.agilitihealth.com

Address : 6625 West 78th Street, Minneapolis, MN, United States, 55439

Employees : 3,900

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 0.74

52 Week High : 26.36

Short Ratio : 6.81

52 Week Low : 13.56

Shorted Shares : 1,249,497

200 Day Moving Average : 19.71

Shorted Shares Previous Month : 1,222,890

50 Day Moving Average : 20.30

Shares Held By Insiders : 1.09%

Short Percentage : 1.00%

Shares Held by Institutions : 100.18%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-09-22 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VEEV Veeva Systems Inc

-1.19 (-0.40%)

 USD46.32B 113.98 90.26
TDOC Teladoc Health Inc

+0.07 (+0.05%)

 USD22.07B N/A N/A
DOCS Doximity Inc.

-2.76 (-3.17%)

 USD16.16B 280.81 212.49
PHR Phreesia Inc

-0.05 (-0.08%)

 USD3.37B 2.91 N/A
AMWL American Well Corporation

-0.13 (-1.26%)

 USD2.56B N/A N/A
EVH Evolent Health Inc

+0.36 (+1.40%)

 USD2.24B N/A 158.95
CNVY Convey Holding Parent Inc.

-0.34 (-4.20%)

 USD0.59B N/A 22.05
CSLT Castlight Health Inc

+0.05 (+3.14%)

 USD0.25B N/A N/A
NXU Novus Capital Corporation II

-0.02 (-0.20%)

 N/A N/A N/A
2175 SMS Co Ltd

N/A

 N/A N/A N/A

ETFs Containing AGTI

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 2.92B 56% F 65% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 3.43 56% F 29% F
Price / Cash Flow Ratio 21.21 44% F 21% F
EV/EBITDA 16.28 100% A+ 36% F
Management Effectiveness  
Return on Equity -0.94% 78% C+ 28% F
Return on Invested Capital 2.63% 78% C+ 41% F
Return on Assets 2.18% 75% C 45% F
Debt to Equity Ratio 259.09% 20% F 12% F
Technical Ratios  
Short Ratio 6.81 44% F 13% F
Short Percent 4.09% 67% D+ 43% F
Beta 0.74 67% D+ 73% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.